TNF and renal cell carcinoma: Additionally, we also assayed the cytokine levels of TNF‐α and IFN‐γ within APCCs treated with anti‐PD1, anti‐PD1, and cabozantinib combination, as well as anti‐PD1 with CD15pos cells' removal in RCC patient‐derived APCCs.